Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chappell

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Diabetologia|March 3, 2009
Functional involvement of protein kinase C-betaII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cellsD S Chappell, N A Patel, K Jiang, et al.
Pain Medicine (Malden, Mass.)|May 21, 2009
Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot studyAimee M Hunter, Andrew F Leuchter, Ian A Cook, et al.
Archives of Biochemistry and Biophysics|June 14, 2002
Phosphoinositide 3-kinase mediates protein kinase C beta II mRNA destabilization in rat A10 smooth muscle cell cultures exposed to high glucoseNiketa A Patel, Mayumi Yamamoto, Philip Illingworth, et al.
Pain Medicine (Malden, Mass.)|July 31, 2007
Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomesDavid G Armstrong, Amy S Chappell, Trong K Le, et al.
Psychosomatics|August 19, 2009
Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritisMadelaine M Wohlreich, Mark D Sullivan, Craig H Mallinckrodt, et al.
Pain|July 24, 2009
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trialAmy S Chappell, Melissa J Ossanna, Hong Liu-Seifert, et al.
Pain Medicine (Malden, Mass.)|August 25, 2007
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic painJoachim F Wernicke, Fujun Wang, Yili L Pritchett, et al.
Research in Veterinary Science|November 29, 2016
Longitudinal study of CTX-M ESBL-producing E. coli strains on a UK dairy farmR A Horton, D Duncan, L P Randall, et al.
Arthritis Research & Therapy|July 16, 2010
Effect of duloxetine in patients with fibromyalgia: tiredness subgroupsLaurence A Bradley, Robert Bennett, Irwin J Russell, et al.
Clinical Rheumatology|June 18, 2009
Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trialsErnest H S Choy, Philip J Mease, Daniel K Kajdasz, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Diabetologia|March 3, 2009
Functional involvement of protein kinase C-betaII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cellsD S Chappell, N A Patel, K Jiang, et al.
Pain Medicine (Malden, Mass.)|May 21, 2009
Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot studyAimee M Hunter, Andrew F Leuchter, Ian A Cook, et al.
Archives of Biochemistry and Biophysics|June 14, 2002
Phosphoinositide 3-kinase mediates protein kinase C beta II mRNA destabilization in rat A10 smooth muscle cell cultures exposed to high glucoseNiketa A Patel, Mayumi Yamamoto, Philip Illingworth, et al.
Pain Medicine (Malden, Mass.)|July 31, 2007
Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomesDavid G Armstrong, Amy S Chappell, Trong K Le, et al.
Psychosomatics|August 19, 2009
Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritisMadelaine M Wohlreich, Mark D Sullivan, Craig H Mallinckrodt, et al.
Pain|July 24, 2009
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trialAmy S Chappell, Melissa J Ossanna, Hong Liu-Seifert, et al.
Pain Medicine (Malden, Mass.)|August 25, 2007
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic painJoachim F Wernicke, Fujun Wang, Yili L Pritchett, et al.
Research in Veterinary Science|November 29, 2016
Longitudinal study of CTX-M ESBL-producing E. coli strains on a UK dairy farmR A Horton, D Duncan, L P Randall, et al.
Arthritis Research & Therapy|July 16, 2010
Effect of duloxetine in patients with fibromyalgia: tiredness subgroupsLaurence A Bradley, Robert Bennett, Irwin J Russell, et al.
Clinical Rheumatology|June 18, 2009
Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trialsErnest H S Choy, Philip J Mease, Daniel K Kajdasz, et al.
Pageof 12